230 related articles for article (PubMed ID: 29626382)
1. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
2. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
3. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
[TBL] [Abstract][Full Text] [Related]
4. Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer.
Li D; Lu Y; Zhao F; Yan L; Yang X; Wei L; Yang X; Yuan X; Yang K
PeerJ; 2022; 10():e14115. PubMed ID: 36221263
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
Song H; Peng JS; Dong-Sheng Y; Yang ZL; Liu HL; Zeng YK; Shi XP; Lu BY
Braz J Med Biol Res; 2012 Jan; 45(1):78-85. PubMed ID: 22124703
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G
J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260
[TBL] [Abstract][Full Text] [Related]
7. Plasma sample based analysis of gastric cancer progression using targeted metabolomics.
Lario S; Ramírez-Lázaro MJ; Sanjuan-Herráez D; Brunet-Vega A; Pericay C; Gombau L; Junquera F; Quintás G; Calvet X
Sci Rep; 2017 Dec; 7(1):17774. PubMed ID: 29259332
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
10. A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis.
Chen Y; Zhang J; Guo L; Liu L; Wen J; Xu L; Yan M; Li Z; Zhang X; Nan P; Jiang J; Ji J; Zhang J; Cai W; Zhuang H; Wang Y; Zhu Z; Yu Y
Oncotarget; 2016 Dec; 7(52):87496-87510. PubMed ID: 27589838
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of therapeutic mechanism of Weiweifang on experimental gastric ulcer in rats viewing from metabonomics].
Peng SL; Liu XW; Zhang ZR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Oct; 30(10):1073-7. PubMed ID: 21066893
[TBL] [Abstract][Full Text] [Related]
14. Targeted Metabolomic Profiling of Plasma Samples in Gastric Cancer by Liquid Chromatography-Mass Spectrometry.
Matsumoto T; Fukuzawa M; Itoi T; Sugimoto M; Aizawa Y; Sunamura M; Kawai T; Nemoto D; Shinohara H; Muramatsu T; Suzuki Y; Kagawa Y; Suguro M; Uchida K; Koyama Y; Madarame A; Morise T; Yamaguchi H; Sugimoto A; Yamauchi Y; Kono S; Naito S
Digestion; 2023; 104(2):97-108. PubMed ID: 36404717
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance-based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis.
Gu J; Huang C; Hu X; Xia J; Shao W; Lin D
Cancer Sci; 2020 Sep; 111(9):3195-3209. PubMed ID: 32369664
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
17. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry.
Wu H; Xue R; Tang Z; Deng C; Liu T; Zeng H; Sun Y; Shen X
Anal Bioanal Chem; 2010 Feb; 396(4):1385-95. PubMed ID: 20012946
[TBL] [Abstract][Full Text] [Related]
19. Significance of sucrose permeability test in detecting early gastric cancer and changes of permeability after endoscopic mucosal resection.
Yamaguchi T; Shishido T; Hara T; Ohyama N; Sudo K; Nakamura K; Denda T; Ishihara T; Yokosuka O; Nomura F
Hepatogastroenterology; 2009; 56(90):561-4. PubMed ID: 19579643
[TBL] [Abstract][Full Text] [Related]
20. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]